RivaroxabanEpistaxis and major abdominal bleeding: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1926卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24695-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：417 / 417

相关论文

共 50 条

[1] RivaroxabanEpistaxis or intracranial haemorrhage: 2 case reports
Reactions Weekly, 2024, 2025 (1) : 418 - 418
[2] Aspirin/warfarinGastrointestinal bleeding and major bleeding: 2 case reports
Reactions Weekly, 2019, 1776 (1) : 90 - 90
[3] WarfarinCerebral infarction and major bleeding: 2 case reports
Reactions Weekly, 2025, 2041 (1) : 399 - 399
[4] Apixaban/thalidomideRash and major bleeding : 2 case reports
Reactions Weekly, 2019, 1750 (1) : 49 - 49
[5] HeparinPostoperative bleeding and abdominal compartment syndrome: 2 case reports
Reactions Weekly, 2020, 1794 (1) : 112 - 112
[6] Multiple drugsIntra-abdominal bleeding: 2 case reports
Reactions Weekly, 2021, 1849 (1) : 306 - 306
[7] Apixaban/rivaroxabanEpistaxis, haemorrhagic pleural effusion, and bleeding from other lesions: 3 case reports
Reactions Weekly, 2021, 1879 (1) : 56 - 56
[8] Dabigatran etexilate/rivaroxabanUterine major bleeding and gastrointestinal bleeding: 2 case reports
Reactions Weekly, 2018, 1695 (1) : 134 - 134
[9] Rivaroxaban/warfarinGI bleeding and major bladder bleeding consisting of haematuria: 2 case reports
Reactions Weekly, 2020, 1814 (1) : 316 - 316
[10] Alteplase/dabigatran-etexilateClinically relevant non-major bleeding and major bleeding: 2 case reports
Reactions Weekly, 2020, 1818 (1) : 24 - 24

← 1 2 3 4 5 →